T Cell Involvement in Neuroinflammation After Traumatic Brain Injury: Implications for Therapeutic Intervention.
Mitchell D Kilgore1, Yuwen Xiu1, Yinghua Jiang1
1Clinical Neuroscience Research Center, Departments of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
CNS Neuroscience & Therapeutics
|August 26, 2025
Summary
Traumatic brain injury (TBI) triggers neuroinflammation involving T cells, which can worsen secondary injury. Targeting T cell responses may offer new therapeutic strategies for TBI patients.
Area of Science:
- Neuroimmunology
- Traumatic Brain Injury Research
Background:
- Traumatic brain injury (TBI) is a major global cause of death and disability.
- Secondary injury after TBI is exacerbated by neuroinflammation, with no targeted treatments currently available.
- T cells are increasingly recognized for their dual role in TBI pathogenesis and repair.
Purpose of the Study:
- To review T cell functionality in TBI, including response characteristics and activation mechanisms.
- To examine T cell contributions to neuroinflammation and pathological factors influencing TBI.
- To summarize therapeutic T cell modulation strategies and identify future research directions.
Main Methods:
- Comprehensive literature review of T cell responses in TBI.
- Analysis of temporospatial T cell dynamics and activation pathways.
- Evaluation of existing therapeutic interventions and research gaps.
Main Results:
- T cells exhibit diverse roles in TBI, influencing both secondary injury and repair processes.
- Neuroinflammation following TBI is significantly modulated by T cell activity.
- Existing literature highlights potential therapeutic targets within the T cell response to TBI.
Conclusions:
- Specific aspects of the T cell response to TBI present promising therapeutic targets.
- Further translational research is crucial for developing effective TBI treatments.
- Modulating T cell activity could lead to novel strategies for managing TBI.


